Hydroxychloroquine and the risk of respiratory infections among RA patients.
Joel M KremerGeorge ReedDimitrios A PappasL R HaroldKevin KaneJeffrey GreenbergKevin WinthropPublished in: RMD open (2021)
In patients with RA, the risk for respiratory infections was similar among patients using HCQ as compared to other non-biologic DMARDs.